Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody.
par Topping, Louise LM;Thomas, Bethan L;Rhys, Hefin HI;Tremoleda, Jordi JL;Foster, Martyn;Seed, Michael;Voisin, Mathieu-Benoit;Vinci, Chiara ;Law, Hannah L;Perretti, Mauro;Norling, Lucy LV;Azevedo, Helena S;Nissim, Ahuva
Référence Frontiers in immunology, 11, page (10)
Publication Publié, 2020-01-01
Référence Frontiers in immunology, 11, page (10)
Publication Publié, 2020-01-01
Article révisé par les pairs
Titre: |
|
Auteur: | Topping, Louise LM; Thomas, Bethan L; Rhys, Hefin HI; Tremoleda, Jordi JL; Foster, Martyn; Seed, Michael; Voisin, Mathieu-Benoit; Vinci, Chiara; Law, Hannah L; Perretti, Mauro; Norling, Lucy LV; Azevedo, Helena S; Nissim, Ahuva |
Informations sur la publication: | Frontiers in immunology, 11, page (10) |
Statut de publication: | Publié, 2020-01-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | anti-TNF |
collagen II | |
extracellular vesicles (EV) | |
monoclonal antibodies | |
rheumatoid arthritis | |
MeSH keywords: | Animals |
Anti-Inflammatory Agents -- administration & dosage | |
Antibodies, Monoclonal -- administration & dosage -- immunology | |
Arthritis, Experimental -- drug therapy | |
Arthritis, Rheumatoid -- drug therapy | |
Cartilage -- immunology -- pathology | |
Drug Delivery Systems -- methods | |
Extracellular Vesicles | |
Female | |
Healthy Volunteers | |
Humans | |
Interleukin-10 -- administration & dosage | |
Knee Joint -- drug effects | |
Leukocytes -- cytology | |
Mice | |
Mice, Inbred C57BL | |
Treatment Outcome | |
Tumor Necrosis Factor-alpha -- immunology | |
Viral Proteins -- administration & dosage | |
Langue: | Anglais |
Identificateurs: | urn:issn:1664-3224 |
info:doi/10.3389/fimmu.2020.00010 | |
info:pmid/32117219 | |
PMC7033748 |